Today

Agents

Chat

Arena

Discover

More

App

Acrivon Therapeutics, Inc Q2 Income From Operations USD -18.668 Million - ACRV News | Rallies

Acrivon Therapeutics, Inc Q2 Income From Operations USD -18.668 Million

ACRV•2026-08-12

Quarterly results

Aug. 12 (Reuters) - Acrivon Therapeutics, Inc Q2 basic EPS USD -0.43.

Q2 net income USD -17.964 million
Q2 operating expenses USD 18.668 million

Related News

Workhorse expands Motive GM Holdings cash-flow credit facility to $40 million

WKHS•2026-08-12

Cannae Holdings publishes investor presentation on shift toward sports and entertainment assets

CNNE•2026-08-12

Battalion Oil Q2 revenue rises on higher prices despite lower output

BATL

•

2026-08-12

Gen Digital Head of Products Travis Witteveen sells 30,000 shares for $882,558.00

GEN•2026-08-12

DeFi Development Q2 revenue rises on digital asset treasury growth

DFDV•2026-08-12